Most people who travel to the Amazon for an ayahuasca retreat aren't doing it because of a research paper. They're going because something in their life isn't working — a depression that won't lift, a trauma they can't seem to metabolize, an addiction that keeps winning. The science usually shows up later, after the fact, as a kind of validation for what they already felt happen.

But the science is finally catching up. A naturalistic study tracking 63 people who attended ayahuasca ceremonies at a retreat center deep in the Peruvian Amazon offers one of the more interesting data points we have on what this brew may actually do to mental health — and, more surprisingly, to the way certain genes express themselves. The findings are worth understanding if you're seriously weighing whether plant medicine might help you.

Here's what the researchers found, what it means in plain language, and what it doesn't mean. Because in the world of ayahuasca and psychedelics, the gap between hype and evidence is wide enough to fall into.

The Setup: A Real Retreat, Not a Lab

What makes this study unusual is where it took place. Most psychedelic research happens in sterile clinical settings — fluorescent lights, eye masks, a therapist in a chair, synthetic compounds dosed by milligram. This one happened at an actual retreat in the rainforest, with traditionally prepared brew, Shipibo-style ceremonies, and the kind of conditions people actually book when they travel to Peru.

Participants filled out standardized psychological questionnaires three times: before their first ceremony, the morning after their last one, and again six months later. The instruments were the ones clinicians use — the Beck Depression Inventory, the State-Trait Anxiety Inventory, the Self-Compassion Scale, a global distress measure called CORE-OM, and a childhood trauma questionnaire. Saliva samples were also collected before and after the retreat to look at something most psychedelic studies have never examined: epigenetic change.

That last piece matters. Epigenetics is the layer of biology that sits on top of your DNA and tells genes when to switch on or off. Trauma — especially childhood trauma — is known to leave epigenetic marks. The question the researchers wanted to ask was whether ayahuasca might somehow reach down to that level.

What Happened to Depression, Anxiety, and Self-Compassion

The psychological results were, frankly, striking. Depression scores dropped substantially between pre-retreat and the morning after the final ceremony. Anxiety scores dropped. Global distress dropped. Self-compassion — which is a slower-moving trait that's notoriously hard to shift — went up significantly. And here's the part that matters most: when participants were re-tested six months later, those improvements held. In some cases they had deepened slightly.

The effect sizes were large by clinical research standards. We're talking Cohen's d values north of 0.8 across multiple measures, which is the kind of number that would make a pharmaceutical company very excited if it came from a pill they were trying to sell.

A few things worth flagging honestly:

• This was naturalistic, not randomized or placebo-controlled. People who travel to the Amazon for ayahuasca are self-selecting, motivated, and often already primed for change.
• The follow-up depended on people answering an email six months later. Drop-off in that kind of design tends to skew positive — the people doing well are more likely to respond.
• None of this proves ayahuasca caused the improvements. It proves an association, in a specific population, in a specific setting.

That said, the pattern is consistent with what other research on ayahuasca and psilocybin has shown: meaningful, sustained reductions in depression and anxiety after a small number of carefully-held experiences. The brew isn't doing nothing.

The Trauma Connection That Surprised the Researchers

One of the more interesting threads in the study had to do with childhood trauma. Participants who scored higher on the childhood trauma questionnaire showed greater improvement in depression after the retreat. Read that twice. The people walking in with the heaviest histories tended to come out with the biggest shifts.

That tracks with a theory that's been circulating in the plant-medicine world for a long time — that ayahuasca seems to do something specific around stored trauma, memory, and the emotional weight attached to old experiences. Practitioners talk about it in mystical terms. Researchers are starting to talk about it in terms of memory reconsolidation, fear extinction, and the brain's ability under psychedelics to re-file traumatic material with less of a charge attached.

There's a caveat the study authors are careful about, and you should be too. The same mechanism that lets someone reprocess trauma can re-traumatize them if the setting is wrong — bad facilitator, no preparation, no aftercare, no container to actually integrate what comes up. This is one of the reasons the question of where you do this work matters as much as whether you do it at all.

The Epigenetic Finding: A First in Psychedelic Research

Here's the part that made this paper genuinely novel. The team looked at DNA methylation on two genes — SIGMAR1 and FKBP5 — both of which have been implicated in stress, mood regulation, and psychiatric vulnerability. SIGMAR1 in particular is interesting because the alkaloids in ayahuasca are thought to bind to and modulate that receptor.

After the retreat, methylation on SIGMAR1 had shifted significantly. Even more intriguingly, the people with higher childhood trauma scores showed larger methylation changes. This is the first time any psychedelic has been shown to produce a measurable epigenetic shift in a human study.

Now — and this is important — nobody knows yet what that shift actually means at the level of biology. A 2% change in methylation might translate into meaningful changes in how the gene gets expressed, or it might be biological noise. Hypermethylation typically silences genes, but it can also do other things depending on where on the gene it lands. The researchers are appropriately cautious. What they've found is a signal worth chasing, not a conclusion.

Still: the idea that a few nights of ceremony might reach down into the epigenetic layer — the same layer that trauma writes onto in the first place — is genuinely new territory. If it holds up in larger studies, it reframes what we think these master plants are actually doing.

What This Means If You're Considering a Retreat

Reading a study like this can do one of two things. It can push you toward booking the first retreat that comes up in a Google search. Or it can make you a smarter, more careful consumer of an experience that deserves real care. The second is better.

A few honest thoughts on translating research into a decision:

1. The setting in the study was traditional and held by experienced facilitators. The improvements people had didn't come from drinking ayahuasca in a hotel room. They came from a full retreat container — dieta, ceremony, integration, time in the jungle. If you cut corners on the container, you shouldn't expect the same results.
2. Childhood trauma showed up as a positive predictor, but also as a risk factor. If you're carrying a serious trauma history, screen retreats hard. Ask about facilitator credentials, medical screening, what happens when someone has a difficult night, and what integration support looks like after you leave.
3. Six-month follow-up was where the durability lived. The interesting story isn't what happens during the ceremony. It's what people do with it afterward — therapy, lifestyle changes, the slow work of letting an insight become a habit.
4. Don't treat one study as a green light or a guarantee. The evidence is encouraging. It is not yet the kind of evidence that justifies framing ayahuasca as a treatment. It's a tradition that some people find profoundly helpful, with growing scientific support and real risks.

Where the Science Goes From Here

The honest state of psychedelic research on ayahuasca is that we have a handful of small studies, a lot of anecdote, and the beginning of a serious attempt to understand mechanism. The epigenetic angle in particular opens a door. If trauma can be passed down through generations via epigenetic marks — and there's real evidence suggesting it can — then the question of whether a psychedelic might help unwrite some of those marks becomes one of the most important questions in mental health.

We're not there yet. The samples are too small, the controls too loose, the mechanisms too poorly understood. But the trajectory is clear, and the people working on it are serious. For anyone watching this space because they're hoping it might help with their own depression, addiction, or trauma, that should be cautious good news.

If something in this study resonates with where you are right now and you want to look further, a range of carefully vetted ayahuasca retreats can be browsed on our marketplace here. Whatever you decide, decide slowly — the brew has been around for centuries, and it will still be there next month while you do your homework.